Skip to main navigation Skip to search Skip to main content

Cytoxic activity of the novel cdk inhibitor, AZ12580005 in chronic lymphocytic leukaemia

Project Details

Short titleCytoxic activity of the novel cdk inhibitor, AZ12580005 in chronic lymphocytic leukaemia
StatusFinished
Effective start/end date1/01/08 → 31/12/08

Funding

  • AstraZeneca, United Kingdom